CHRIS PRIES: Open Payments
NPI 1205897337 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 8 payments from 6 companies in 2025. Trend: 2023 $263 · 2024 $317 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: Auvelity, ABILIFY MAINTENA, VRAYLAR, VIVITROL, AUSTEDO XR, ARISTADA, UZEDY, INVEGA SUSTENNA.
Industry payments across IA — which companies pay providers there.
